Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study-Reference-Cited by-同舟云学术

Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study

Published:2021-08 Issue: Volume:49 Page:101-112
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Ip Cheng-Teng,Olbrich Sebastian,Ganz Melanie,Ozenne Brice,Köhler-Forsberg Kristin,Dam Vibeke H.,Beniczky Sándor,Jørgensen Martin B.,Frokjaer Vibe G.,Søgaard Birgitte,Christensen Søren R.,Knudsen Gitte M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference40 articles.

1. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study;Arns;Clin. Neurophysiol.,2016

2. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study;Arns;Clin. Neurophysiol.,2016

3. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: Implications for treatment outcome?;Arns;Eur. Neuropsychopharmacol.,2015

4. The neurobiology of the EEG biomarker as a predictor of treatment response in depression;Baskaran;Neuropharmacology,2012

5. HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder;Bech;Pharmacopsychiatry,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive modeling of antidepressant efficacy based on cognitive neuropsychological theory;Journal of Affective Disorders;2024-06

2. Frontal Alpha Asymmetry and Its Modulation by Monoaminergic Neurotransmitters in Depression;Clinical Psychopharmacology and Neuroscience;2024-03-04

3. Die Rolle des EEG als Neuro-Marker für Patienten mit Depression: Ein systematischer Überblick;Fortschritte in der nicht-invasiven biomedizinischen Signalverarbeitung mit ML;2024

4. Technical and clinical considerations for electroencephalography-based biomarkers for major depressive disorder;npj Mental Health Research;2023-10-25

5. Accelerated TMS - moving quickly into the future of depression treatment;Neuropsychopharmacology;2023-05-22